15
Participants
Start Date
November 18, 2015
Primary Completion Date
April 8, 2019
Study Completion Date
April 8, 2019
SPK-9001
A novel, bioengineered adeno-associated viral vector carrying human factor IX variant
Royal Prince Alfred Hospital, Camperdown/Sydney
Weill Cornell Medicine - New York Presbyterian Hospital, New York
The Children's Hospital of Philadelphia, Philadelphia
Mississippi Center for Advanced Medicine, Madison
University of Mississippi Medical Center, Jackson
UC Davis Comprehensive Cancer Center, Sacramento
UC Davis CTSC Clinical Research Center, Sacramento
UC Davis Ellison Ambulatory Care Clinic, Sacramento
UC Davis Investigational Pharmacy, Sacramento
UC Davis Medical Center, Sacramento
Lead Sponsor
Pfizer
INDUSTRY